Redmile Group, LLC Alx Oncology Holdings Inc Transaction History

Redmile Group, LLC

$1.28 Billion
Q4 2024

A detailed history of Redmile Group, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Redmile Group, LLC holds 3,689,611 shares of ALXO stock, worth $3.69 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

3,689,611

Previous 3,836,576 3.83%

Holding current value

$3.69 Million

Previous $6.98 Million 11.76%

% of portfolio

0.48%

Previous 0.46%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.21 - $1.87 $177,827 - $274,824	-146,965 Reduced 3.83%	3,689,611 $6.16 Million
Q3 2024 Nov 14, 2024	SELL	$1.81 - $8.13 $361,773 - $1.62 Million	-199,875 Reduced 4.95%	3,836,576 $6.98 Million
Q2 2024 Aug 14, 2024	SELL	$5.84 - $17.56 $1.69 Million - $5.09 Million	-290,058 Reduced 6.7%	4,036,451 $24.3 Million
Q1 2024 May 15, 2024	BUY	$10.95 - $16.79 $7.31 Million - $11.2 Million	667,245 Added 18.23%	4,326,509 $48.2 Million
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $11.4 Million - $36.5 Million	2,375,975 Added 185.15%	3,659,264 $54.5 Million
Q2 2023 Aug 14, 2023	BUY	$4.37 - $9.56 $3.04 Million - $6.66 Million	696,312 Added 118.63%	1,283,289 $9.64 Million
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $92,628 - $239,973	-20,493 Reduced 3.37%	586,977 $2.65 Million
Q4 2022 Feb 14, 2023	SELL	$9.51 - $12.95 $1.38 Million - $1.87 Million	-144,627 Reduced 19.23%	607,470 $6.85 Million
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $120,981 - $222,558	-14,700 Reduced 1.92%	752,097 $7.2 Million
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $32,984 - $108,976	-5,600 Reduced 0.73%	766,797 $6.2 Million
Q1 2022 May 16, 2022	SELL	$13.65 - $22.06 $132,405 - $213,982	-9,700 Reduced 1.24%	772,397 $13.1 Million
Q4 2021 Feb 14, 2022	SELL	$21.49 - $74.4 $1.77 Million - $6.13 Million	-82,338 Reduced 9.53%	782,097 $16.8 Million
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $2.6 Million - $4.01 Million	-49,600 Reduced 5.43%	864,435 $63.8 Million
Q2 2021 Aug 16, 2021	SELL	$52.2 - $75.23 $3.37 Million - $4.86 Million	-64,565 Reduced 6.6%	914,035 $50 Million
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $1.14 Million - $1.6 Million	18,200 Added 1.9%	978,600 $72.2 Million
Q4 2020 Feb 16, 2021	BUY	$34.11 - $112.26 $18.9 Million - $62.1 Million	553,000 Added 135.74%	960,400 $82.8 Million
Q3 2020 Nov 16, 2020	BUY	$29.36 - $47.1 $12 Million - $19.2 Million	407,400 New	407,400 $15.4 Million

Others Institutions Holding ALXO

# of Institutions

Shares Held

39.5M

Call Options Held

213K

Put Options Held

44.8K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $40.7M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Alx Oncology Holdings Inc Transaction History